The Amazon effect
The pharma industry needs to transform the supply chain from a source of regulatory risk to a legitimate business opportunity.
Read More
Search Results for: Bill Fox
US biotechs “lobbying states to restrict access to biosimilars”
Industry and consumer groups are urging action against what they say is lobbying by biotechnology companies of US state legislators aimed at restricting access to biosimilar versions of branded biologic drugs.
Read MoreUS Senator probes $20M Obama health care PR deal
A leading US Senator is seeking more information on the $20 million contract recently awarded by the Department of Health and Human Services (HHS) to a public relations firm to advertise President Barack Obama’s Affordable Care Act (ACA).
Read MoreRoche stock falls as Avastin fails in colon cancer trial
Roche has suffered a major setback on the news that its oncology blockbuster Avastin has failed in a study looking at the treatment’s effectiveness in early-stage colon cancer.
Read MoreEarnings leap but analysts hoping for more from Pfizer
Profits have soared at Pfizer, as strong international sales and cost-cutting measures saw net income triple for the third quarter.
Read More- Cambridge researchers develop robotic nerve devices for neurological conditions
- International phase 3 clinical trial for new melanoma treatment recruits first patients
- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
